## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-26T12:00:09.108Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Vivy: GLP1 & GLP 1 Tracker"
developer_entity: "Vita Intelligence, Inc."
bundle_id: "app.getvita.vita"
app_store_id: "6736508784"
category: "Health & Fitness"
primary_platform: "ios"
primary_monetization: "Subscription"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2026-03-26"
report_date: "2026-05-26"
last_verified: "2026-05-26"
report_version: "3.4.4"
total_reviews: 653
overall_rating: 4.77
sentiment: "Excited"
sentiment_score: 85
confidence: "medium"
confidence_score: 0.6
review_sample_size: 48
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 4
nemesis: "Shotsy GLP-1 Tracker"
competitor_count: 11
tags: ["health & fitness", "subscription", "excited sentiment", "mobile app", "app review", "app analysis", "individuals", "prescribed", "glp-1"]
canonical_url: "https://marlvel.ai/intel-report/health-fitness/vivy-glp1-glp-1-tracker"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# Vivy: GLP1 & GLP 1 Tracker App Audit

## TL;DR {#tldr}

- **Category**: Health & Fitness · Subscription
- **Signal**: Rating 4.77 · Sentiment Excited

> **TL;DR:** Vivy: GLP1 & GLP 1 Tracker is a health & fitness app by Vita Intelligence, Inc., rated 4.77/5 by 653 users, with Excited user sentiment (85/100), available on iOS.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Vivy: GLP1 & GLP 1 Tracker has Excited user sentiment with a 4.77/5 rating from 653 reviews.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.77/5 (653 reviews) |
| **User Mood** | Excited |
| **Category** | Health & Fitness |
| **Developer** | Vita Intelligence, Inc. |
| **Pricing** | Subscription |
| **Platforms** | iOS |
| **Confidence** | Medium (0.6/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** Vita Intelligence, Inc.
- **Category:** Health & Fitness
- **Target Audience:** Individuals prescribed GLP-1 medications like Zepbound, Wegovy, or Ozempic seeking structured health tracking and clinical-led guidance.
- **Platforms:** iOS
- **Version Audited:** 3.4.4
- **Audit Date:** 2026-05-26
- **Signal Count:** 48 reviews analyzed
- **Confidence:** Medium (0.6/1.0)
- **App Store ID (iOS):** 6736508784
- **Bundle ID:** app.getvita.vita
- **Performance Trend:** Improving
- **Data Window:** Analysis based on signals collected up to 2026-05-26

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Vivy is a doctor-developed health tracking app for GLP-1 medication users on iOS.
**Why users hire it:** Users hire Vivy to manage medication side effects and weight loss progress within a clinically-vetted community, reducing the confusion of self-managed treatment.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] GLP-1 Specific Community:** Dedicated forum for users on GLP-1 medications to share experiences and ask questions
  * *User Intent:* Users seek social connection and competitive engagement with peers.
- **[Differentiator] Photo-based Food Tracking:** Nutrient tracking via image capture of meals to monitor protein intake
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Habit-based Coaching System:** Personalized guidance and check-ins designed by a board-certified obesity medicine doctor
  * *User Intent:* Users value self-expression and personalized experiences.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Vivy maintains a 4.77 rating across 653 ratings, establishing a high-trust niche position. The subscription-only model limits mass-market adoption compared to utility-first competitors.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Subscription
- **Tiers:** Yearly, Monthly
- **Analysis:** Subscription-only model for core features, requiring payment via Apple account with auto-renewal.

<!-- section:sentiment -->
## 🟢 User Sentiment (Medium Confidence: 653 reviews) {#user-sentiment}
- **Overall Rating:** 4.77/5
- **Platform Split:** iOS 4.8/5 (653 ratings)
- **Overall Sentiment:** Excited

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Doctor-developed positioning builds clinical trust
- GLP-1 specific community fosters peer-to-peer retention

**Critical Frictions:**
- Subscription-only model for core features limits top-of-funnel conversion
- Lack of automated device integration increases manual logging friction

**Growth Levers:**
- Integration with wearable biosensors for objective metabolic data
- B2B partnerships with clinics for patient management

**Market Threats:**
- Shotsy’s predictive medication visualization tools
- Apple Health integration dominance by established medical apps

<!-- /section:swot -->
## Recent Changes (v3 → v4) {#recent-changes}

Vivy has improved its sentiment standing and refined its competitive focus toward GLP-1 specific rivals, though it remains constrained by a subscription-only barrier.

**Overall trend**: Improving
**Compared at**: 2026-05-26

### High-impact changes
- **[Improved] Sentiment Score Increase** (sentiment) — Overall sentiment score increased from 45 to 85, shifting the status from mixed to positive.
- **[Shifted] Competitive Landscape Update** (positioning) — Replaced generic weight loss competitors with GLP-1 specific rivals like Shotsy and Stelo to better reflect the current market.

### Medium-impact changes
- **[Shifted] Weakness and Threat Refinement** (swot) — Weaknesses now highlight lack of automated device integration; threats shifted from Noom to Shotsy and Apple Health integration dominance.
- **[Shifted] PM Action Item Pivot** (positioning) — Priorities shifted from fixing data-persistence crashes to implementing free-tier tracking and Apple Health integration.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### Vivy: GLP1 & GLP 1 Tracker vs Shotsy GLP-1 Tracker — Head to Head
- **[Shotsy GLP-1 Tracker](https://marlvel.ai/intel-report/health-fitness/com-everyday-shottracker)** by Shotsy: Shotsy is the direct market leader in the GLP-1 niche, competing for the same user base seeking specialized medication tracking and dosage visualization.
  - **Key differences:**
    - Advanced medication level estimation provides users with predictive insights into their current drug concentration levels.
    - High-frequency release cadence ensures rapid feature iteration and responsiveness to user feedback and platform updates.
    - Massive review volume creates a significant social proof barrier that is difficult for new entrants to overcome.
  - **Where Vivy: GLP1 & GLP 1 Tracker wins:**
    - ✅ Doctor-developed positioning builds higher clinical trust compared to Shotsy’s general-purpose utility branding.
    - ✅ Focused, streamlined UX avoids the feature bloat that can overwhelm new GLP-1 users.
  - **Where Shotsy GLP-1 Tracker wins:**
    - ❌ Superior data visualization tools for tracking medication levels over time provide deeper clinical utility.
    - ❌ Extensive Apple Health integration allows for seamless data synchronization with existing user health ecosystems.
  - **Verdict:** Vivy must pivot toward clinical authority and unique educational content to differentiate from Shotsy’s pure-utility dominance.

### Contenders (Strong Challengers)
- **[Medisafe Carezone: PillMemo](https://marlvel.ai/intel-report/medical/medisafe-carezone-pillmemo)** by Marcin Jedrzejak: PillMemo competes on the basis of simple, unlimited medication tracking and inventory management for patients with complex regimens.
  - Inventory management features help users track medication supply levels, preventing missed doses due to stockouts.
  - Unlimited notification and tracking capabilities provide a flexible, low-barrier entry for medication management.
- **[Pill Reminder MyTherapy](https://marlvel.ai/intel-report/medical/pill-reminder-mytherapy)** by smartpatient GmbH: MyTherapy is a mature, high-trust medical app that competes for users who prioritize medication adherence and clinical reporting.
  - Long-standing reputation and clinical validation provide a level of security that newer niche apps lack.
  - Comprehensive medication refill reminders and clinical reporting tools offer a complete end-to-end patient management solution.
- **[Blood Sugar Diary for Diabetes](https://marlvel.ai/intel-report/medical/blood-sugar-diary-for-diabetes)** by MedM Inc: This app targets the medical-grade tracking segment, appealing to users who require Bluetooth connectivity and multi-parameter health logging.
  - Direct Bluetooth device connectivity automates data entry, eliminating manual logging errors for chronic condition management.
  - Clinical-grade reporting features allow users to export comprehensive data sets directly to their healthcare providers.
- **[GLP-1 Tracker: Pep](https://marlvel.ai/intel-report/medical/com-shredapps-glp1)** by Shred Apps, LLC: Pep competes by offering a broader lifestyle-focused feature set, including AI-driven food scanning and injection site rotation.
  - AI-powered food scanning reduces friction for users attempting to manage diet alongside GLP-1 medication.
  - Dedicated injection site rotation tracking addresses a specific pain point for long-term medication adherence.

### Peers (What They Do Better)
- **[Medicamentos Colsubsidio](https://marlvel.ai/intel-report/medical/com-colsubsidio-appmedicamentos)** by Colsubsidio: This app competes in the broader medication management ecosystem by facilitating pharmacy logistics and appointment booking.
  - Integrated home delivery scheduling for medications creates a tangible logistical advantage over pure tracking apps.
  - In-person appointment booking capabilities bridge the gap between digital tracking and physical healthcare services.
- **[Gluroo CGM Watchface](https://marlvel.ai/intel-report/health-fitness/gluroo-cgm-watchface)** by Gluroo Imaginations Inc.: Gluroo targets the power-user segment that requires real-time synchronization between CGM data and insulin pump management.
  - Real-time CGM complications on the watch face provide immediate visibility into critical health metrics.
  - Advanced synchronization between mobile apps and insulin pumps creates a closed-loop management experience.
- **[Stelo by Dexcom](https://marlvel.ai/intel-report/health-fitness/com-dexcom-stelo)** by Dexcom: Stelo competes by providing hardware-backed biosensor data, which is the gold standard for metabolic health monitoring.
  - Direct integration with continuous glucose biosensors offers objective, real-time metabolic data rather than manual logs.
  - Backed by Dexcom’s established brand and infrastructure, providing a high-trust environment for health-conscious users.
- **[Sweet Dreams – Sugar Tracker](https://marlvel.ai/intel-report/medical/com-marwan-sugartrack)** by Marwan Elwaraki: This app overlaps by focusing on the metabolic health and blood sugar tracking aspects often associated with GLP-1 usage.
  - Live Activity and Dynamic Island widgets provide real-time, glanceable health data without opening the app.
  - Integrated community messaging groups foster peer-to-peer support, which is absent in purely clinical tracking apps.

### New Kids on the Block (What's Innovative)
- **[Pill Reminder: Med-Alarm](https://marlvel.ai/intel-report/health-fitness/pill-reminder-med-alarm)** by Ramkumar Vellaisamy: This newcomer enters the space with a privacy-first approach to medication reminders and history tracking.
  - Privacy-first architecture ensures sensitive health data remains local, appealing to security-conscious medication users.
- **[Easy GLP 1 Tracker](https://marlvel.ai/intel-report/health-fitness/easy-glp-1-tracker)** by Dropouts Technologies LLP: A new entrant focusing on Apple Intelligence and clinical reporting to capture users looking for modern, automated insights.
  - Leverages Apple Intelligence to provide automated, personalized health insights based on user-logged symptoms and weight.

<!-- /section:rivals -->
<!-- section:whats-new -->
## What's New

- **Latest (v2.13.1, 11 months ago):** Added image support for meals, community/profile meal sharing, and optimized saved meal logging.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Maintains consistent clinical-led update cadence.
- Ships community-focused feature iterations.

> **Cadence:** 5 total versions · 0 majors in last 6 months · 60 days since last update · 29 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Vivy: GLP1 & GLP 1 Tracker is a market-leading health & fitness app that is available.
With a 4.77/5 rating from 653 reviews, it delivers strong user satisfaction.

<!-- speakable-start -->
> **Bottom Line:** Vivy holds a strong clinical niche through doctor-led positioning, but the subscription-only barrier leaves it exposed to utility-first rivals, so the team must prioritize free-tier tracking to drive user acquisition.
<!-- speakable-end -->

**Best for:** Individuals prescribed GLP-1 medications like Zepbound, Wegovy, or Ozempic seeking structured health tracking and clinical-led guidance.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [HIGH IMPACT] Ship free-tier basic tracking because subscription-only core features limit top-of-funnel conversion → increase install velocity — *Subscription-only model for core features is the primary barrier to entry.* _(trade-off: deprioritize Pause the coaching-system expansion — top-of-funnel growth is the current priority.)_
- [ ] [PIVOT] [MEDIUM IMPACT] Integrate Apple Health data sync because lack of automated device integration increases manual logging friction → improve retention — *Competitors like Blood Sugar Diary offer automated entry, making manual logging a competitive disadvantage.* _(trade-off: deprioritize Deprioritize the community forum UI refresh — data utility is a higher churn risk.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- Automated device connectivity (available in Blood Sugar Diary but missing here)
- Predictive medication level estimation (available in Shotsy but missing here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Stable

The GLP-1 tracking market is consolidating around utility-first apps that offer automated data synchronization. Vivy must transition from a manual-entry tool to a clinical data hub to remain relevant, or risk losing its user base to competitors with superior device integration.

- 🟢 High rating consistency indicates the clinical-led value proposition resonates with the core user base, stabilizing retention.
- 🔴 Subscription-only access to core features creates a conversion bottleneck that limits growth against free-to-use utility competitors.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.77/5 |
| Total Reviews | 653 |
| Sentiment | Excited (85/100) |
| Confidence | Medium |
| Pricing Model | Subscription |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Improving |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Vivy: GLP1 & GLP 1 Tracker** (this app) | 4.77/5 | Excited | Vita Intelligence, Inc. |
| [Shotsy GLP-1 Tracker](https://marlvel.ai/intel-report/health-fitness/com-everyday-shottracker) | 4.8/5 | Excited | Shotsy |
| [Sweet Dreams – Sugar Tracker](https://marlvel.ai/intel-report/medical/com-marwan-sugartrack) | 4.7/5 | N/A | Marwan Elwaraki |
| [Medicamentos Colsubsidio](https://marlvel.ai/intel-report/medical/com-colsubsidio-appmedicamentos) | 2.8/5 | N/A | Colsubsidio |
| [Stelo by Dexcom](https://marlvel.ai/intel-report/health-fitness/com-dexcom-stelo) | 2.9/5 | N/A | Dexcom |
| [Blood Sugar Diary for Diabetes](https://marlvel.ai/intel-report/medical/blood-sugar-diary-for-diabetes) | 4.5/5 | Excited | MedM Inc |

## Company Profile
- **Developer:** Vita Intelligence, Inc.
- **Website:** [https://www.getvivy.com/](https://www.getvivy.com/)
- **Social:** [Instagram](https://www.instagram.com/vivy_glp1) · [Facebook](https://www.facebook.com/profile.php?id=61560178464713) · [TikTok](https://www.tiktok.com/@theglp1app)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/vivy-glp1-glp-1-tracker/id6736508784?uo=4)
- **Dev Site:** [Official Website](https://www.getvivy.com/)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*Shotsy GLP-1 Tracker*](https://marlvel.ai/intel-report/health-fitness/com-everyday-shottracker) (Shotsy) — 4.8/5 Rating | Positive Sentiment
- [*Sweet Dreams – Sugar Tracker*](https://marlvel.ai/intel-report/medical/com-marwan-sugartrack) (Marwan Elwaraki) — 4.7/5 Rating | N/A Sentiment
- [*Medicamentos Colsubsidio*](https://marlvel.ai/intel-report/medical/com-colsubsidio-appmedicamentos) (Colsubsidio) — 2.8/5 Rating | N/A Sentiment
- [*Stelo by Dexcom*](https://marlvel.ai/intel-report/health-fitness/com-dexcom-stelo) (Dexcom) — 2.9/5 Rating | N/A Sentiment
- [*Blood Sugar Diary for Diabetes*](https://marlvel.ai/intel-report/medical/blood-sugar-diary-for-diabetes) (MedM Inc) — 4.5/5 Rating | Positive Sentiment
- [*Pill Reminder MyTherapy*](https://marlvel.ai/intel-report/medical/pill-reminder-mytherapy) (smartpatient GmbH) — 4.8/5 Rating | Mixed Sentiment
- [*Pill Reminder: Med-Alarm*](https://marlvel.ai/intel-report/health-fitness/pill-reminder-med-alarm) (Ramkumar Vellaisamy) — N/A Rating | N/A Sentiment
- [*Easy GLP 1 Tracker*](https://marlvel.ai/intel-report/health-fitness/easy-glp-1-tracker) (Dropouts Technologies LLP) — N/A Rating | N/A Sentiment
- [*Gluroo CGM Watchface*](https://marlvel.ai/intel-report/health-fitness/gluroo-cgm-watchface) (Gluroo Imaginations Inc.) — 3.9/5 Rating | N/A Sentiment
- [*Medisafe Carezone: PillMemo*](https://marlvel.ai/intel-report/medical/medisafe-carezone-pillmemo) (Marcin Jedrzejak) — 4.9/5 Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 48
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/health-fitness/vivy-glp1-glp-1-tracker)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.